Abstract:We have read with great interest the letter from Dr. Leal-Noval et al. regarding our paper. They raise several questions we are pleased to provide answers.In the TRAHT study [<a href="#CR1">1</a>], the mean hemoglobin concentration during the first 14 days after hospital admission was 9.3 ± 1.3 g/dL in the liberal group and 8.4 ± 1.0 g/dL in the restrictive group (p p <a href="#CR6">6</a>].The TRAHT study was a randomized clinical trial, meaning the only difference between groups after randomization was the transfusion strategy. After randomization, the patients in the liberal group receive a total of 66 red blood cells (RBCs) units as compared with 35 RBC units in the restrictive group (p = 0.02), with a good protocol adherence. However, the sample size was small, which may have led to unbalanced groups. The restrictive group had more pupil alterations and more midline deviation ≥ 5 mm on brain CT, and more patients received blood transfusions before randomization compared to the liberal group 9 (43%) vs. 15 (65%), respectively. Nevertheless, the study groups were statistically well matched at baseline with respect to demographic and clinical characteristics. Although not statistically significant, it might suggest that the restrictive group would be more severely injured than the liberal group and this could explain part of the reported secondary outcomes.Several experimental, physiological, and observational data point toward an increase in the brain tissue oxygen partial pressure (PbtO2) in anemic neurocritical patients that received RBC transfusion [<a href="#CR7">7</a>]. If these results translate into better patient-centered outcomes, whether PbtO2 could be used to identify the patients which benefit from RBC transfusion remains to be determined.Anemia as well as RBC transfusion is associated with worse outcomes in TBI patients [<a href="#CR8">8</a>, <a href="#CR9">9</a>]. However, these data come from observational trials which are deeply susceptible to confusion bias, even after statistical analysis of the data and are particularly influenced by the patients' severity. The most severe TBI patients are anemic, and the most severe anemic TBI patients receive blood transfusion. Thus, TBI patients receiving blood transfusion would be always associated with worse outcomes in this setting. Therefore, only an adequately powered randomized clinical trial could answer the question if a strategy aimed at correcting anemia by RBC transfusion could benefit severe TBI patients. TRAHT was a pilot trial, aimed at evaluating the feasibility of a randomized clinical trial comparing liberal and restrictive blood transfusion strategies in patients with moderate and severe TBI. Although its secondary analysis in favor of the liberal transfusion strategy was noteworthy, we agree that the study results should be interpreted cautiously.

Association of hemoglobin concentration and mortality in critically ill patients with severe traumatic brain injury

Haemoglobin values, transfusion practices, and long-term outcomes in critically ill patients with traumatic brain injury: a secondary analysis of CENTER-TBI

Need for Blood Transfusion Volume Is Associated With Increased Mortality in Severe Traumatic Brain Injury

Red Blood Cell Transfusion and Transfusion Alternatives in Traumatic Brain Injury

Transfusion practices for acute traumatic brain injury: a survey of physicians at US trauma centers

Hemoglobin levels and transfusions in neurocritically ill patients: a systematic review of comparative studies

Effect of albumin and hemoglobin level on prognosis of patients with uncomplicated severe traumatic brain injury: a retrospective cohort study

Transfusion requirements after head trauma: a randomized feasibility controlled trial

Red blood cell transfusion may be more detrimental than anemia for the clinical outcome of patients with severe traumatic brain injury

The choice of blood transfusion strategy in severe traumatic brain injury

Anemia and red blood cell transfusion in neurocritical care

Haemoglobin transfusion threshold in traumatic brain injury optimisation (HEMOTION): a multicentre, randomised, clinical trial protocol

Association Between Whole Blood Transfusion and Mortality Among Patients With Hemorrhagic Shock and Traumatic Brain Injury

Association Between Percutaneous Oxygen Saturation and Mortality of Patients with Mild Traumatic Brain Injury at ICU Admission: An Analysis of the MIMIC-III Database

Low hemoglobin is associated with poor functional outcome after non-traumatic, supratentorial intracerebral hemorrhage

Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage

Association of initial assessment variables and mortality in severe pediatric traumatic brain injury

Critical traumatic brain injury is associated with worse coagulopathy

A review of traumatic brain injury trauma center visits meeting physiologic criteria from The American College of Surgeons Committee on Trauma/Centers for Disease Control and Prevention Field Triage Guidelines

Biochemical and Radiological Factors for Prognostication of Traumatic Brain Injury: An Institutional Experience

Effect of Increasing Blood Pressure on Brain Tissue Oxygenation in Adults After Severe Traumatic Brain Injury